Aminoquinazoline compounds as A2A antagonist

The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Wu, Heping, Tagat, Jayaram R, Lee, Joe, Hong, Liwu, de Lera Ruiz, Manuel, Cao, Jianhua, Lo, Michael Man-Chu, Zhou, Gang, Kuang, Rongze, Yu, Tao, Xiao, Yushi, Biju, Purakkattle, Berlin, Michael, Ting, Pauline C, Degrado, Sylvia J, Kim, Dong Won-Shik, Tung, Alexander L, Wu, Jie, Kim, Jae-Hun, Lim, Yeon-Hee, Henderson, Timothy J, Zhu, Xiaohong, Ali, Amjad, Khan, Tanweer, McCormick, Kevin D, Xiao, Dong, Zhang, Yonglian
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.